Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Receivables - Other: 2024-2025

Historic Receivables - Other for Gossamer Bio (GOSS) over the last 2 years, with Sep 2025 value amounting to $400,000.

  • Gossamer Bio's Receivables - Other rose 300.00% to $400,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $400,000, marking a year-over-year increase of 300.00%. This contributed to the annual value of $200,000 for FY2024, which is N/A change from last year.
  • Per Gossamer Bio's latest filing, its Receivables - Other stood at $400,000 for Q3 2025, which was down 0.00% from $400,000 recorded in Q2 2025.
  • Over the past 5 years, Gossamer Bio's Receivables - Other peaked at $400,000 during Q2 2025, and registered a low of $100,000 during Q3 2024.
  • In the last 2 years, Gossamer Bio's Receivables - Other had a median value of $250,000 in 2024 and averaged $250,000.
  • Data for Gossamer Bio's Receivables - Other shows a peak YoY skyrocketed of 300.00% (in 2025) over the last 5 years.
  • Gossamer Bio's Receivables - Other (Quarterly) stood at $200,000 in 2024, then spiked by 300.00% to $400,000 in 2025.
  • Its last three reported values are $400,000 in Q3 2025, $400,000 for Q2 2025, and $100,000 during Q1 2025.